We are live on ! Find out more
EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
-20.92%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$216M
AUM Growth
-$67.4M
Cap. Flow
-$4.32M
Cap. Flow %
-2%
Top 10 Hldgs %
82.29%
Holding
30
New
5
Increased
6
Reduced
4
Closed
4

Top Buys

1
TVTX icon
Travere Therapeutics
TVTX
+$19.7M
2
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
+$8.86M
3
ASMB icon
Assembly Biosciences
ASMB
+$4.59M
4
CASC
Cascadian Therapeutics, Inc.
CASC
+$3.22M
5
OREX
Orexigen Therapeutics, Inc.
OREX
+$3.21M

Top Sells

1
ATRA icon
Atara Biotherapeutics
ATRA
+$12.7M
2
EPZM
Epizyme, Inc
EPZM
+$3.9M
3
ARRY
Array Biopharma Inc
ARRY
+$2.88M
4
BITI
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
+$2M
5
FWP
Forward Pharma A/S American Depositary Shares
FWP
+$1.71M

Sector Composition

1 Healthcare 76.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYNB
1
Kyntra Bio
KYNB
$29.5M
$27M 12.48%
49,216
+1,000
+2% +$606K
ATRA icon
2
Atara Biotherapeutics
ATRA
$76.9M
$25.3M 11.69%
32,138
-10,390
-24% -$12.7M
TVTX icon
3
Travere Therapeutics
TVTX
$5.28B
$20.4M 9.44%
1,007,660
+666,010
+195% +$19.7M
EPZM
4
DELISTED
Epizyme, Inc
EPZM
$19.2M 8.88%
1,492,700
-193,100
-11% -$3.9M
ASMB icon
5
Assembly Biosciences
ASMB
$529M
$18M 8.35%
157,256
+26,080
+20% +$4.59M
KITE
6
DELISTED
Kite Pharma, Inc.
KITE
$15.7M 7.25%
281,400
– –
DCOY
7
Decoy Therapeutics
DCOY
$2.98M
$11.2M 5.19%
1
– –
COLL icon
8
Collegium Pharmaceutical
COLL
$1.16B
$10.3M 4.76%
465,118
– –
ATYR
9
aTyr Pharma
ATYR
$51.4M
$8.62M 3.99%
60,033
+257
+0.4% +$58.6K
NBRV
10
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$7.94M 3.67%
+3,342
New +$8.86M
KIN
11
DELISTED
Kindred Biosciences, Inc.
KIN
$6.88M 3.18%
1,323,431
+29,000
+2% +$179K
GNVC
12
DELISTED
GenVec, Inc.
GNVC
$4.59M 2.12%
198,641
– –
EIGR
13
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.98M 1.38%
6,318
– –
CASC
14
DELISTED
Cascadian Therapeutics, Inc.
CASC
$2.58M 1.2%
+157,250
New +$3.22M
AKTX
15
Akari Therapeutics
AKTX
$21.5M
$2.42M 1.12%
+126
New +$1.49M
FWP
16
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$2.4M 1.11%
14,571
-8,141
-36% -$1.71M
FPRX
17
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$2.29M 1.06%
+149,000
New +$3.2M
CALA
18
DELISTED
Calithera Biosciences, Inc
CALA
$2.26M 1.04%
20,774
– –
OREX
19
DELISTED
Orexigen Therapeutics, Inc.
OREX
$1.98M 0.92%
+93,796
New +$3.21M
QLTI
20
DELISTED
QLT Inc
QLTI
$1.7M 0.79%
638,900
+238,900
+60% +$877K
GYRE icon
21
Gyre Therapeutics
GYRE
$732M
$261K 0.12%
498
-289
-37% -$441K
BHC icon
22
Bausch Health
BHC
$1.82B
– –
0
– –
GILD icon
23
Gilead Sciences
GILD
$164B
– –
0
– –
MCRB icon
24
Seres Therapeutics
MCRB
$53.5M
– –
-2,000
Closed -$1.66M
RGLS
25
DELISTED
Regulus Therapeutics
RGLS
– –
0
– –
1
2

Similar funds

G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
BAM
Berkshire Asset Management Wilkes Barre, Pennsylvania $2.33B AUM 19.33% 1-Year Est. Return
CC
Capital Counsel New York $2.35B AUM 21.34% 1-Year Est. Return
HFM
Harvest Fund Management Beijing, China $2.35B AUM 49.85% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $2.33B AUM 92.42% 1-Year Est. Return
ST
Sageworth Trust Lancaster, Pennsylvania $2.33B AUM 20.04% 1-Year Est. Return
MFAM
Motley Fool Asset Management Alexandria, Virginia $2.33B AUM 21.93% 1-Year Est. Return